How can we be sure that renal dysfunction after coronary angiography is just explained by contrast nephropathy? [8] (multiple letters)

Kidney International

Volumn 66, Issue 4, 2004, Pages 1717-1718

  Canavese, Caterina ^a   Morra, Fabio ^c   Morellini, Veronica ^c   Lazzarich, Elisa ^c   Brustia, Maddalena ^c   Bo, Mario ^c   Stratta, Piero ^c   Tonelli, Marcello ^b   Manns, Braden ^c   Pannu, Neesh ^c  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b CSB 11 107   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CHOLESTEROL; CONTRAST MEDIUM; CREATININE;

ANGIOCARDIOGRAPHY; ARTERY OCCLUSION; CLINICAL TRIAL; CONTRAST NEPHROPATHY; CREATININE BLOOD LEVEL; DRUG EFFICACY; EOSINOPHILIA; FAT EMBOLISM; HEALTH CARE COST; HUMAN; INCIDENCE; KIDNEY DISEASE; LETTER; META ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS;

EID: 4644313776     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.938_12.x     Document Type: Letter

References (3)

1. K.S. Modi V.K. Rao Atheroembolic renal disease J Am Soc Nephrol 12 2001 1781 1787
2. G. Ramirez W.M. O'Neill Jr. R. Lambert Cholesterol embolization: A complication of angiography Arch Intern Med 138 1978 1430 1432
3. A.V. Kshirsagar C. Poole A. Mottl N-acetylcysteine for the prevention of radiocontrast induced nephropathy: A meta-analysis of prospective controlled trials J Am Soc Nephrol 15 2004 761 769